Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Wynne

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Medicine, Health Care, and Philosophy|March 31, 2011
The ethics of 'public understanding of ethics'--why and how bioethics expertise should include public and patients' voicesSilke Schicktanz, Mark Schweda, Brian Wynne
Public Understanding of Science (Bristol, England)|October 28, 2010
Taxonomy, biodiversity and their publics in twenty-first-century DNA barcodingRebecca Ellis, Claire Waterton, Brian Wynne
Nature|August 24, 2012
Conservation policy: Listen to the voices of experienceEsther Turnhout, Bob Bloomfield, Mike Hulme, et al.
Innovations in Clinical Neuroscience|September 27, 2018
Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIb Clinical Trials in HIV-infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)Clare Brennan, Hannah Whillis, Choy Man, et al.
Journal of Clinical Pharmacology|December 3, 2014
Pharmacokinetics of dolutegravir when administered with mineral supplements in healthy adult subjectsIvy Song, Julie Borland, Niki Arya, et al.
Nature Biotechnology|December 10, 2013
Science-based risk assessment requires careful evaluation of all studiesFern Wickson, Thomas Bøhn, Brian Wynne, et al.
Clinical Pharmacology in Drug Development|July 15, 2021
Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Abacavir/Dolutegravir/Lamivudine Combination Tablets in Healthy Japanese Study ParticipantsRajendra P Singh, Kimberly Adkison, Allen Wolstenholme, et al.
International Journal of Antimicrobial Agents|October 19, 2002
Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanateThomas M File, Michael R Jacobs, Michael D Poole, et al.
Journal of the International AIDS Society|November 14, 2014
The effect of dolutegravir on the pharmacokinetics of metformin in healthy subjectsJian Zong, Julie Borland, Fred Jerva, et al.
British Journal of Clinical Pharmacology|May 20, 2014
Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravirMark Johnson, Julie Borland, Shuguang Chen, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Medicine, Health Care, and Philosophy|March 31, 2011
The ethics of 'public understanding of ethics'--why and how bioethics expertise should include public and patients' voicesSilke Schicktanz, Mark Schweda, Brian Wynne
Public Understanding of Science (Bristol, England)|October 28, 2010
Taxonomy, biodiversity and their publics in twenty-first-century DNA barcodingRebecca Ellis, Claire Waterton, Brian Wynne
Nature|August 24, 2012
Conservation policy: Listen to the voices of experienceEsther Turnhout, Bob Bloomfield, Mike Hulme, et al.
Innovations in Clinical Neuroscience|September 27, 2018
Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIb Clinical Trials in HIV-infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)Clare Brennan, Hannah Whillis, Choy Man, et al.
Journal of Clinical Pharmacology|December 3, 2014
Pharmacokinetics of dolutegravir when administered with mineral supplements in healthy adult subjectsIvy Song, Julie Borland, Niki Arya, et al.
Nature Biotechnology|December 10, 2013
Science-based risk assessment requires careful evaluation of all studiesFern Wickson, Thomas Bøhn, Brian Wynne, et al.
Clinical Pharmacology in Drug Development|July 15, 2021
Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Abacavir/Dolutegravir/Lamivudine Combination Tablets in Healthy Japanese Study ParticipantsRajendra P Singh, Kimberly Adkison, Allen Wolstenholme, et al.
International Journal of Antimicrobial Agents|October 19, 2002
Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanateThomas M File, Michael R Jacobs, Michael D Poole, et al.
Journal of the International AIDS Society|November 14, 2014
The effect of dolutegravir on the pharmacokinetics of metformin in healthy subjectsJian Zong, Julie Borland, Fred Jerva, et al.
British Journal of Clinical Pharmacology|May 20, 2014
Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravirMark Johnson, Julie Borland, Shuguang Chen, et al.
Pageof 8